Table 3.
Study author (year) | Design | Enrolled sample size (baseline) by condition | Target behavior | Retention at end of CM condition | Eligible ages (mean) | Longest follow-up | Type of reinforcement | Reinforcement schedule | Maximum possible incentives for CM condition | Primary outcome: CM condition(s) Mean or % | Primary outcome: Control condition (s) Mean or % |
---|---|---|---|---|---|---|---|---|---|---|---|
DeFulio et al. (2021) | N-RCT | Enrolled CM = 85, Matched control = 85 | Drug and alcohol abstinence, treatment engagement | 100 % | N/R | None | Reloadable debit card | Escalating with reset and constant rate | $436 | CM vs. control: Months 1, 2, 3, 4: 14.12, 17.65, 16.47 & 20 percentage point increases in consistent samples, respectively; 7.28, 9.55, 13.62 & 18.01 percentage point increases in attendance, respectively. | |
Hammond et al. (2021) | RCT | CM = 29; control = 32 | Drug and alcohol abstinence, treatment engagement | N/R | 18+ (M = 39.6) | 1 month | Reloadable debit card | Escalating with reset | $600 | Mean days in usual care treatment: 29.8; Treatment retention rate: 24 %; Rate of recent abstinence: 33 % | Mean days in usual care treatment: 22.2; Treatment retention rate: 3 %; Rate of recent abstinence: 16 % |
Holtyn et al. (2021) | RCT | CM = 21; control = 20 | Intervention engagement | 100 % | 18+ (M = 47.1) | None | Reloadable credit card | Constant rate | $350 | % enrolled in treatment: 71 % | % enrolled in treatment: 30 % |
Raiff et al. (2021) | WS | Enrolled sample (n = 8) | Nicotine vaping abstinence | 100 % | 18–35 (M = 19.9) | None | Reloadable debit card | Escalating with reset | $140 | PNS (<30 % ng/ml cotinine): 77 % | PNS (<30 % ng/ml cotinine): 0 % |
Abbreviations: WS = Within Subjects Design; RCT = Randomized Control Trial Design; N-RCT = Non-Randomized Control Trial Design; CM = Contingency Management Condition; M = mean; N/R = Not Reported; PNS = Percent Negative Samples.